CeGaT

Analyzes tumor DNA and RNA to find targetable variants and transcriptome changes that can inform treatment.

Vetted listing

Treatment OptionsTesting3 offerings

Consented intake · your records travel with you · nothing moves without your sign-off

Why CeGaT exists

CeGaT offers DNA and RNA sequencing of tumor tissue. DNA sequencing maps variants to uncover what is driving the cancer, with whole exome data useful when a personalized vaccine is under consideration. RNA sequencing looks for transcriptome abnormalities that may inform treatment. Together these give patients a fuller genetic picture before choosing a therapy.

CAP and CLIA accreditedDIN EN ISO 15189 and ISO/IEC 17025 accreditedDIN EN ISO/IEC 27001 certifiedBased in Tuebingen, Germany, since 2009

Prefer the source? CeGaT's own site has more.

Share your records

We'll pre-fill the intake from your records — no retyping.

Start sharing →

Check your coverage

See if your insurance covers this and estimate out-of-pocket cost.

Check coverage →

What they offer

Treatment Options

Access a treatment uniquely tailored to my disease to turbocharge my immune system

Testing· 2

Uncover what genetic coding is driving my cancer, especially those variants of interest that can be targeted for treatment
Uncover any abnormalities in the transcriptome that may inform treatment

Coverage, insurance & cost

The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how CeGaT handles billing.

We don't have confirmed insurance details for CeGaT yet. Start a coverage check with your plan, or contact the provider directly.

Understand this before you decide

myCeGaT Portal Information and FAQ

Guide from CeGaT

Diagnostic Support

Guide from CeGaT

Sample Shipment Information

Guide from CeGaT

Ask about this service

Answers grounded in CeGaT's details here. Educational only; your oncologist directs treatment.

Also consider

Other providers in similar categories.

Foundation Medicine

6 offerings

FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.